newsfilter
← Latest News
ACCESS Newswire·

As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR Congo

SHELTON, CT / ACCESS Newswire / June 15, 2026 / NanoViricides, Inc. , a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides announces that its proposal to